Evaluation of molnupiravir analogues as novel coronavirus (SARS CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors – an in silico docking and ADMET simulation study | Zendy

AI Assistant Blog Pricing

Evaluation of molnupiravir analogues as novel coronavirus (SARS CoV-2) RNA-dependent RNA polymerase (RdRp) inhibitors – an in silico docking and ADMET simulation study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.